In order to verify whether QDG alleviates cardiac hypertrophy via regulating the NF-κB signaling pathway, we further used a selective NF-κB inhibitor, SC75741 in NRCMs following Ang II-induced cardiac hypertrophy. The gene discussed is NFKB1; the disease is cardiac hypertrophy.